Asia Pac Allergy.  2012 Jan;2(1):3-14. 10.5415/apallergy.2012.2.1.3.

Infection, eosinophilia and childhood asthma

• Kim CK
• Callaway Z
• Fujisawa T

• KMID: 2397406
• DOI: http://doi.org/10.5415/apallergy.2012.2.1.3

Abstract

There is a growing list of viruses and bacteria associated with wheezing illness and asthma. It is well known that a few of these pathogens are strongly associated with wheezing illness and asthma exacerbations. What is not known is if early childhood infections with these pathogens cause asthma, and, if so, exactly what are the pathophysiologic mechanisms behind its development. The current consensus is respiratory infection works together with allergy to produce the immune and physiologic conditions necessary for asthma diasthesis. One link between respiratory infection and asthma may be the eosinophil, a cell that plays prominently in asthma and allergy, but can also be found in the body in response to infection. In turn, the eosinophil and its associated products may be novel therapeutic targets, or at the very least used to elucidate the complex pathophysiologic pathways of asthma and other respiratory illnesses. Together or separately, they can also be used for diagnosis, treatment and monitoring. The optimal care of a patient must take into consideration not only symptoms, but also the underlying disease mechanisms.

Keyword

Asthma; Eosinophilia; Eosinophil-derived neurotoxin; Infection; Respiratory virus; Wheezing

MeSH Terms

Asthma*
Bacteria
Consensus
Diagnosis
Eosinophil-Derived Neurotoxin
Eosinophilia*
Eosinophils
Humans
Hypersensitivity
Respiratory Sounds
Eosinophil-Derived Neurotoxin

Figure

• 

  Fig. 1 Infection of bronchial epithelial cells leads to release of mediators, including cytokines, chemokines, and growth factors. Recruited immune cells (eosinophils, neutrophils, and mast cells) release a number of mediators, as well. CCL, CC chemokine ligand; CXCL, CXC chemokine ligand; ECP, eosinophil cationic protein; EDN, eosinophilderived neurotoxin; EPO, eosinophil peroxidase; FGF-2, fibroblast growth factor-2; GM-CSF, granulocyte macrophage-colony stimulating factor; IL, interleukin; LT, leukotriene; MBP, major basic protein; PAF, platelet activating factor; PG, prostaglandin; TNF, tumour necrosis factor; VEGF, vascular endothelial growth factor.

Reference

1. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005; 171:137–141. PMID: 15516534.

2. Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol. 2005; 16:386–392. PMID: 16101930.

3. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999; 354:541–545. PMID: 10470697.

4. Kotaniemi-Syrjänen A, Vainionpää R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma? J Allergy Clin Immunol. 2003; 111:66–71. PMID: 12532098.

5. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J. 2003; 22:S76–S82. PMID: 12671456.

6. Wu P, Dupont WD, Griffin MR, Carroll KN, Mitchel EF, Gebretsadik T, Hartert TV. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med. 2008; 178:1123–1129. PMID: 18776151.

7. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med. 1995; 332:133–138. PMID: 7800004.

8. Mcintosh K. Kliegman RM, Behrman RE, Jenson HB, Stanton BF, Nelson WE, editors. Respiratory syncytial virus. Nelson textbook of pediatrics. 2007. Philadelphia: Saunders;p. 1388–1390.

9. Wenzel SE, Gibbs RL, Lehr MV, Simoes EA. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. Am J Med. 2002; 112:627–633. PMID: 12034412.

10. Simoes EA, Groothuis JR, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick LM, Kimpen JL. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007; 151:34–42. 42.e1PMID: 17586188.

11. Lemanske RF Jr. Viral infections and asthma inception. J Allergy Clin Immunol. 2004; 114:1023–1026. PMID: 15536404.

12. Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, Kirk CJ, Reisdorf E, Roberg KA, Anderson EL, Carlson-Dakes KT, Adler KJ, Gilbertson-White S, Pappas TE, Dasilva DF, Tisler CJ, Gern JE. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005; 116:571–577. PMID: 16159626.

13. Miller EK, Lu X, Erdman DD, Poehling KA, Zhu Y, Griffin MR, Hartert TV, Anderson LJ, Weinberg GA, Hall CB, Iwane MK, Edwards KM. Rhinovirus-associated hospitalizations in young children. J Infect Dis. 2007; 195:773–781. PMID: 17299706.

14. Johnston SL. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc Am Thorac Soc. 2007; 4:267–270. PMID: 17607011.

15. Lee WM, Kiesner C, Pappas T, Lee I, Grindle K, Jartti T, Jakiela B, Lemanske RF Jr, Shult PA, Gern JE. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One. 2007; 2:e966. PMID: 17912345.

16. Korppi M, Kotaniemi-Syrjänen A, Waris M, Vainionpää R, Reijonen TM. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 2004; 23:995–999. PMID: 15545853.

17. Papadopoulos NG, Moustaki M, Tsolia M, Bossios A, Astra E, Prezerakou A, Gourgiotis D, Kafetzis D. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002; 165:1285–1289. PMID: 11991880.

18. Kusel MM, de Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J. 2006; 25:680–686. PMID: 16874165.

19. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee WM, Shult PA, Reisdorf E, Carlson-Dakes KT, Salazar LP, DaSilva DF, Tisler CJ, Gern JE, Lemanske RF Jr. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008; 178:667–672. PMID: 18565953.

20. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly PD. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007; 119:1105–1110. PMID: 17353039.

21. Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, Contoli M, Sanderson G, Kon OM, Papi A, Jeffery PK, Stanciu LA, Johnston SL. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008; 105:13562–13567. PMID: 18768794.

22. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005; 102:12891–12896. PMID: 16118271.

23. Allander T. Human bocavirus. J Clin Virol. 2008; 41:29–33. PMID: 18055252.

24. Chung JY, Han TH, Kim SW, Kim CK, Hwang ES. Detection of viruses identified recently in children with acute wheezing. J Med Virol. 2007; 79:1238–1243. PMID: 17597481.

25. Vallet C, Pons-Catalano C, Mandelcwajg A, Wang A, Raymond J, Lebon P, Gendrel D. Human bocavirus: a cause of severe asthma exacerbation in children. J Pediatr. 2009; 155:286–288. PMID: 19619752.

26. Castro-Rodríguez JA, Holberg CJ, Wright AL, Halonen M, Taussig LM, Morgan WJ, Martinez FD. Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med. 1999; 159:1891–1897. PMID: 10351936.

27. Jartti T, van den Hoogen B, Garofalo RP, Osterhaus AD, Ruuskanen O. Metapneumovirus and acute wheezing in children. Lancet. 2002; 360:1393–1394. PMID: 12423987.

28. Kim CK, Choi J, Callaway Z, Kim HB, Chung JY, Koh YY, Shin BM. Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in Seoul, Korea, 2003-2008. J Korean Med Sci. 2010; 25:342–347. PMID: 20191030.

29. Lemanske RF Jr. Is asthma an infectious disease?: Thomas A. Neff lecture. Chest. 2003; 123:385S–390S. PMID: 12628996.

30. Bezerra PG, Britto MC, Correia JB, Duarte Mdo C, Fonceca AM, Rose K, Hopkins MJ, Cuevas LE, McNamara PS. Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS One. 2011; 6:e18928. PMID: 21533115.

31. Mok JY, Waugh PR, Simpson H. Mycoplasma pneumoniae infection. A follow-up study of 50 children with respiratory illness. Arch Dis Child. 1979; 54:506–511. PMID: 485193.

32. Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med. 1994; 149:1348–1353. PMID: 8173777.

33. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bønnelykke K, Brasholt M, Heltberg A, Vissing NH, Thorsen SV, Stage M, Pipper CB. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007; 357:1487–1495. PMID: 17928596.

34. Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol. 2006; 144:1–9. PMID: 16542358.

35. Heaton T, Mallon D, Venaille T, Holt P. Staphylococcal enterotoxin induced IL-5 stimulation as a cofactor in the pathogenesis of atopic disease: the hygiene hypothesis in reverse? Allergy. 2003; 58:252–256. PMID: 12653801.

36. Rossi RE, Monasterolo G. Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SAE, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis. Int Arch Allergy Immunol. 2004; 133:261–266. PMID: 14976395.

37. Bachert C, Gevaert P, Howarth P, Holtappels G, van Cauwenberge P, Johansson SG. IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol. 2003; 111:1131–1132. PMID: 12743582.

38. Lee JY, Kim HM, Ye YM, Bahn JW, Suh CH, Nahm D, Lee HR, Park HS. Role of staphylococcal superantigen-specific IgE antibodies in aspirin-intolerant asthma. Allergy Asthma Proc. 2006; 27:341–346. PMID: 17063661.

39. Semic-Jusufagic A, Bachert C, Gevaert P, Holtappels G, Lowe L, Woodcock A, Simpson A, Custovic A. Staphylococcus aureus sensitization and allergic disease in early childhood: populationbased birth cohort study. J Allergy Clin Immunol. 2007; 119:930–936. PMID: 17292957.

40. Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 1998; 11:345–349. PMID: 9551736.

41. Jartti T, Korppi M, Ruuskanen O. The clinical importance of rhinovirus-associated early wheezing. Eur Respir J. 2009; 33:706–707. PMID: 19251814.

42. Juhn YJ, Kita H, Yawn BP, Boyce TG, Yoo KH, McGree ME, Weaver AL, Wollan P, Jacobson RM. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008; 122:719–723. PMID: 18790525.

43. Nicholson KG, Kent J, Ireland DC. Respirator y viruses and exacerbations of asthma in adults. BMJ. 1993; 307:982–986. PMID: 8241910.

44. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, Holgate ST. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995; 310:1225–1229. PMID: 7767192.

45. Rakes GP, Arruda E, Ingram JM, Hoover GE, Zambrano JC, Hayden FG, Platts-Mills TA, Heymann PW. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med. 1999; 159:785–790. PMID: 10051251.

46. Leung TF, To MY, Yeung AC, Wong YS, Wong GW, Chan PK. Multiplex molecular detection of respiratory pathogens in children with asthma exacerbation. Chest. 2010; 137:348–354. PMID: 19749009.

47. Atmar RL, Guy E, Guntupalli KK, Zimmerman JL, Bandi VD, Baxter BD, Greenberg SB. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med. 1998; 158:2453–2459. PMID: 9855383.

48. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002; 324:763. PMID: 11923159.

49. Tarlo SM, Broder I, Corey P, Chan-Yeung M, Ferguson A, Becker A, Rogers C, Okada M, Manfreda J. The role of symptomatic colds in asthma exacerbations: Influence of outdoor allergens and air pollutants. J Allergy Clin Immunol. 2001; 108:52–58. PMID: 11447382.

50. Black PN, Scicchitano R, Jenkins CR, Blasi F, Allegra L, Wlodarczyk J, Cooper BC. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J. 2000; 15:254–259. PMID: 10706488.

51. von Hertzen LC. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur Respir J. 2002; 19:546–556. PMID: 11936537.

52. Lieberman D, Lieberman D, Printz S, Ben-Yaakov M, Lazarovich Z, Ohana B, Friedman MG, Dvoskin B, Leinonen M, Boldur I. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med. 2003; 167:406–410. PMID: 12426232.

53. Emre U, Roblin PM, Gelling M, Dumornay W, Rao M, Hammerschlag MR, Schachter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med. 1994; 148:727–732. PMID: 8019629.

54. Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, Aliberti S, Pappalettera M, Tantardini F, Blasi F. Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res. 2008; 9:48. PMID: 18513407.

55. Velissariou IM, Papadopoulos NG. The role of respiratory viruses in the pathogenesis of pediatric asthma. Pediatr Ann. 2006; 35:637–642. PMID: 16999297.

56. Papadopoulos NG, Xepapadaki P, Mallia P, Brusselle G, Watelet JB, Xatzipsalti M, Foteinos G, van Drunen CM, Fokkens WJ, D'Ambrosio C, Bonini S, Bossios A, Lötvall J, van Cauwenberge P, Holgate ST, Canonica GW, Szczeklik A, Rohde G, Kimpen J, Pitkäranta A, Mäkelä M, Chanez P, Ring J, Johnston SL. Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy. 2007; 62:457–470. PMID: 17324199.

57. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008; 38:709–750. PMID: 18384431.

58. Arnold R, Humbert B, Werchau H, Gallati H, König W. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology. 1994; 82:126–133. PMID: 7519169.

59. Piliponsky AM, Gleich GJ, Bar I, Levi-Schaffer F. Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Mol Immunol. 2002; 38:1369. PMID: 12217410.

60. Rosenberg HF, Dyer KD, Domachowske JB. Respiratory viruses and eosinophils: exploring the connections. Antiviral Res. 2009; 83:1–9. PMID: 19375458.

61. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol. 1994; 56:672–686. PMID: 7996043.

62. Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis. 1998; 177:1458–1464. PMID: 9607820.

63. Rosenberg HF, Domachowske JB. Eosinophils, ribonucleases and host defense: solving the puzzle. Immunol Res. 1999; 20:261–274. PMID: 10741866.

64. Rosenberg HF, Domachowske JB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol. 2001; 70:691–698. PMID: 11698487.

65. Milner JD, Ward JM, Keane-Myers A, Paul WE. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc Natl Acad Sci U S A. 2007; 104:576–581. PMID: 17202252.

66. Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, Rosenberg HF, Foster PS, Matthaei KI. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood. 2007; 110:1578–1586. PMID: 17495130.

67. Kim CK, Chung CY, Kim JS, Kim WS, Park Y, Koh YY. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics. 2000; 105:372–378. PMID: 10654958.

68. Koh YY, Park Y, Lee HJ, Kim CK. Levels of interleukin-2, interferon-γ, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics. 2001; 107:E39. PMID: 11230620.

69. Wongtim S, Mogmued S. Methacholine inhalation challenge in patients with post-Mycoplasma pneumoniae pneumonia. Asian Pac J Allergy Immunol. 1995; 13:5–10. PMID: 7488345.

70. Sabato AR, Martin AJ, Marmion BP, Kok TW, Cooper DM. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child. 1984; 59:1034–1037. PMID: 6508338.

71. Bufford JD, Gern JE. The hygiene hypothesis revisited. Immunol Allergy Clin North Am. 2005; 25:247–262. PMID: 15878454.

72. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989; 299:1259–1260. PMID: 2513902.

73. Oddy WH, de Klerk NH, Sly PD, Holt PG. The effects of respiratory infections, atopy, and breastfeeding on childhood asthma. Eur Respir J. 2002; 19:899–905. PMID: 12030731.

74. Gern JE. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J. 2008; 27:S97–S103. PMID: 18820588.

75. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science. 2002; 296:490–494. PMID: 11964470.

76. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology. 2004; 112:352–363. PMID: 15196202.

77. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001; 108:516–520. PMID: 11590374.

78. Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol. 2003; 111:587–591. PMID: 12642841.

79. Schaub B, Lauener R, von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol. 2006; 117:969–977. PMID: 16675321.

80. Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol. 2002; 109:379–392. PMID: 11897980.

81. Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD, Liu AH. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet. 2000; 355:1680–1683. PMID: 10905243.

82. Brandenburg AH, Kleinjan A, van Het Land B, Moll HA, Timmerman HH, de Swart RL, Neijens HJ, Fokkens W, Osterhaus AD. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol. 2000; 62:267–277. PMID: 11002258.

83. Schaub B, Liu J, Höppler S, Schleich I, Huehn J, Olek S, Wieczorek G, Illi S, von Mutius E. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J Allergy Clin Immunol. 2009; 123:774–782. PMID: 19348917.

84. Oddy WH, Holt PG, Sly PD, Read AW, Landau LI, Stanley FJ, Kendall GE, Burton PR. Association between breast feeding and asthma in 6 year old children: findings of a prospective birth cohort study. BMJ. 1999; 319:815–819. PMID: 10496824.

85. Saarinen UM, Kajosaari M. Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old. Lancet. 1995; 346:1065–1069. PMID: 7564787.

86. Sakamoto M, Ida S, Takishima T. Effect of influenza virus infection on allergic sensitization to aerosolized ovalbumin in mice. J Immunol. 1984; 132:2614–2617. PMID: 6715886.

87. Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Pavord I, Dolovich J, Hargreave FE. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J. 1999; 13:15–21. PMID: 10836317.

88. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med. 2000; 161:64–72. PMID: 10619799.

89. Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. Br Med Bull. 2000; 56:985–1003. PMID: 11359633.

90. Fanat AI, Thomson JV, Radford K, Nair P, Sehmi R. Human airway smooth muscle promotes eosinophil differentiation. Clin Exp Allergy. 2009; 39:1009–1017. PMID: 19438586.

91. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009; 360:973–984. PMID: 19264686.

92. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009; 360:985–993. PMID: 19264687.

93. Moqbel R, Lace P, Adamko DJ, Odemuyiwa SO. Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simons FE, editors. Biology of eosinophils. Allergy: principles & practice. 2008. St. Louis: Mosby;p. 295–310.

94. Gleich GJ, Adolphson CR. Sanderson CJ, editor. The eosinophil and bronchial asthma: evidence for a critical role of eosinophils in pathophysiology. Interleukin-5: from molecule to drug target for asthma (lung biology in health and disease). 1999. New York: Marcel Dekker;p. 1–37.

95. Gupta S, Ross GD, Good RA, Siegal FP. Surface markers of human eosinophils. Blood. 1976; 48:755–763. PMID: 974267.

96. Ebisawa M, Schleimer RP, Bickel C, Bochner BS. Schlossman SF, Boumsel L, Gilks W, Harlan J, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder T, Todd R, editors. Phenotyping of purified human peripheral blood eosinophils using the blind panel mAb. Leucocyte typing V: white cell differentiation antigens: proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. 1995. Volume one. New York: Oxford University Press;p. 1036–1038.

97. Fujii M, Tanaka H, Abe S. Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients. Chest. 2005; 128:3148–3155. PMID: 16304255.

98. Zinchuk O, Fukushima A, Zinchuk V, Fukata K, Ueno H. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. Mol Vis. 2005; 11:114–123. PMID: 15735601.

99. Wang H, Tan X, Chang H, Huang W, Gonzalez-Crussi F, Hsueh W. Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora. Immunology. 1999; 97:447–454. PMID: 10447766.

100. Walsh ER, August A. Eosinophils and allergic airway disease: there is more to the story. Trends Immunol. 2010; 31:39–44. PMID: 19926338.

101. Wang HB, Ghiran I, Matthaei K, Weller PF. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol. 2007; 179:7585–7592. PMID: 18025204.

102. Duez C, Dakhama A, Tomkinson A, Marquillies P, Balhorn A, Tonnel AB, Bratton DL, Gelfand EW. Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. J Allergy Clin Immunol. 2004; 114:820–825. PMID: 15480321.

103. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med. 1981; 305:841–846. PMID: 6168908.

104. Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med. 1999; 159:1918–1924. PMID: 10351940.

105. Wang SZ, Smith PK, Lovejoy M, Bowden JJ, Alpers JH, Forsyth KD. Shedding of L-selectin and PECAM-1 and upregulation of Mac-1 and ICAM-1 on neutrophils in RSV bronchiolitis. Am J Physiol. 1998; 275:L983–L989. PMID: 9815117.

106. Kim CK, Choi J, Kim HB, Callaway Z, Shin BM, Kim JT, Fujisawa T, Koh YY. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation. J Pediatr. 2010; 156:749–754. PMID: 20171653.

107. Kim CK, Kim SW, Park CS, Kim BI, Kang H, Koh YY. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol. 2003; 112:64–71. PMID: 12847481.

108. Ehlenfield DR, Cameron K, Welliver RC. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics. 2000; 105:79–83. PMID: 10617708.

109. Piippo-Savolainen E, Remes S, Korppi M. Does blood eosinophilia in wheezing infants predict later asthma? A prospective 18-20-year follow-up. Allergy Asthma Proc. 2007; 28:163–169. PMID: 17479599.

110. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995; 95:500–505. PMID: 7700748.

111. Frischer T, Halmerbauer G, Gartner C, Rath R, Tauber E, Schierl M, Koller DY, Urbanek R, Förster J, Kühr J. Eosinophil-derived proteins in nasal lavage fluid of neonates of allergic parents and the development of respiratory symptoms during the first 6 months of life. Allergy. 2000; 55:773–777. PMID: 10955705.

112. Karawajczyk M, Pauksen K, Peterson CG, Eklund E, Venge P. The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections. Clin Exp Allergy. 1995; 25:713–719. PMID: 7584682.

113. Niehaus MD, Gwaltney JM Jr, Hendley JO, Newman MJ, Heymann PW, Rakes GP, Platts-Mills TA, Guerrant RL. Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis. J Clin Microbiol. 2000; 38:3100–3102. PMID: 10921988.

114. Hosoki K, Nakamura A, Nagao M, Hiraguchi Y, Tokuda R, Wada H, Nobori T, Fujisawa T. Differential activation of eosinophils by 'probiotic' Bifidobacterium bifidum and 'pathogenic' Clostridium difficile. Int Arch Allergy Immunol. 2010; 152(Suppl 1):83–89. PMID: 20523069.

115. Rajagopalan G, Iijima K, Singh M, Kita H, Patel R, David CS. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun. 2006; 74:1284–1296. PMID: 16428778.

116. Fujimoto K, Kubo K, Matsuzawa Y, Sekiguchi M. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. Chest. 1997; 112:1241–1247. PMID: 9367463.

117. Venge P, Byström J, Carlson M, Hâkansson L, Karawacjzyk M, Peterson C, Sevéus L, Trulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy. 1999; 29:1172–1186. PMID: 10469025.

118. Rosenberg HF. Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem. 1995; 270:7876–7881. PMID: 7713881.

119. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol. 1989; 142:4428–4434. PMID: 2656865.

120. Bystrom J, Amin K, Bishop-Bailey D. Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte. Respir Res. 2011; 12:10. PMID: 21235798.

121. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP, Pantoja C, Erle DJ, Yamamoto KR, Fahy JV. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A. 2007; 104:15858–15863. PMID: 17898169.

122. Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fahy JV, Israel E, Lazarus SC, Lemanske RF Jr, Leone FT, Pesola GR, Peters SP, Sorkness CA, Szwejbka LA, Wechsler ME. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol. 2007; 119:73–80. PMID: 17208587.

123. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol. 2005; 115:233–242. PMID: 15696076.

124. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR, Kay AB. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today. 1999; 20:528–533. PMID: 10529782.

125. Barnes PJ. Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Clin Exp Allergy. 2009; 39:1145–1151. PMID: 19538350.

126. Wark PA, Gibson PG. Asthma exacerbations × 3: Pathogenesis. Thorax. 2006; 61:909–915. PMID: 17008482.

127. Kim CK, Kim JT, Kang H, Yoo Y, Koh YY. Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. Clin Exp Allergy. 2003; 33:1409–1414. PMID: 14519148.

128. Koh YY, Kang H, Kim CK. Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma: comparison between acute exacerbation and clinical remission. Allergy Asthma Proc. 2003; 24:269–274. PMID: 12974194.

129. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol. 1986; 39:177–253. PMID: 3538819.

130. Kim CK, Kim SW, Kim YK, Kang H, Yu J, Yoo Y, Koh YY. Bronchoalveolar lavage eosinophil cationic protein and interleukin-8 levels in acute asthma and acute bronchiolitis. Clin Exp Allergy. 2005; 35:591–597. PMID: 15898980.

131. Kim HB, Kim CK, Iijima K, Kobayashi T, Kita H. Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum. Chest. 2009; 135:295–302. PMID: 19017877.

132. Gibson PG, Woolley KL, Carty K, Murree-Allen K, Saltos N. Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD). Clin Exp Allergy. 1998; 28:1081–1088. PMID: 9761011.

133. Morioka J, Kurosawa M, Inamura H, Nakagami R, Mizushima Y, Omura Y, Shibata M, Chihara J. Increased END/EPX in ongoing asthma. Allergy. 2000; 55:1203–1204. PMID: 11117285.

134. Motojima S, Akutsu I, Fukuda T, Makino S, Takatsu K. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy. 1993; 48:98–106. PMID: 8109721.

135. Venge P. Monitoring the allergic inflammation. Allergy. 2004; 59:26–32. PMID: 14674929.

136. Kim CK, Callaway Z, Fletcher R, Koh YY. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity. J Asthma. 2010; 47:568–573. PMID: 20560830.

137. Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma. Lung. 2007; 185:97–103. PMID: 17393238.

138. Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci. 2001; 26:79–82. PMID: 11323224.